Interferon-Gamma-Inducible Protein 10 (IP-10) Is an Angiostatic Factor That Inhibits Human Non-Small Cell Lung Cancer (NSCLC) Tumorigenesis and Spontaneous Metastases

Journal of Experimental Medicine - United States
doi 10.1084/jem.184.3.981
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Rockefeller University Press

Related search

Plasma Interferon-Gamma-Inducible Protein-10 (IP-10) Levels During Acute Hepatitis C Virus Infection

Hepatology
MedicineHepatology
2013English

Interferon Γ–Inducible Protein-10 (IP-10) and Eotaxin as Biomarkers in Age-Related Macular Degeneration

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2010English

Interferon Regulatory Factor 4 (IRF4) Is Overexpressed in Human Non‑small Cell Lung Cancer (NSCLC) and Activates the Notch Signaling Pathway

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2017English

Interferon Gamma Inhibits Interleukin 10 Production by Monocytes

Journal of Experimental Medicine
MedicineAllergyImmunology
1993English

Interleukin-10-Regulated Tumour Tolerance in Non-Small Cell Lung Cancer

British Journal of Cancer
Cancer ResearchOncology
2017English

METTL7B Is Required for Cancer Cell Proliferation and Tumorigenesis in Non-Small Cell Lung Cancer

Frontiers in Pharmacology
Pharmacology
2020English

ABCC4 Is Required for Cell Proliferation and Tumorigenesis in Non-Small Cell Lung Cancer

OncoTargets and Therapy
OncologyPharmacology
2014English

CXCL10/Gamma Interferon-Inducible Protein 10-Mediated Protection Against Leishmania Amazonensis Infection in Mice

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2006English

Doxycycline Inhibits Electric Field-Induced Migration of Non-Small Cell Lung Cancer (NSCLC) Cells

Scientific Reports
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy